Rob Goodwin

Senior Vice President and Head of Clinical Development & Operations, Pfizer

Rob Goodwin is the Senior Vice President and Head of Clinical Development & Operations within Pfizer Research and Development, a discipline focused on accelerating clinical development innovation and execution with an emphasis on quality, speed, and cost.

Rob has over 30 years of industry experience in clinical operations, safety, and regulatory. He is an executive Six Sigma Black Belt and has been a past member of PhRMA (Pharmaceutical Research and Manufacturers of America), a past board member for CDISC (Clinical Data Interchange Standards Consortium), a current member of the SCDM (Society for Clinical Data Management) advisory board and former co-chair for the Vulcan HL7/TransCelerate research accelerator. In 2021, Rob was recognized in PharmaVoice magazine as one of the top 100 most influential leaders in healthcare.

Rob holds a B.S. in Psychology from Eastern Connecticut State University, a M.S. in Research, Measurement and Evaluation from Southern Connecticut State University and an M.B.A. in Pharmaceutical and Chemical Studies.